PTX

0.00%

3.9¢ prescient therapeutics limited

breakout, page-17

First 17 Last

Share
Profile

Follow
Bretto7970

349 Posts.

107

04/11/21

02:05

Post #: 57299603
Share

Originally posted by BigDaniel: ↑

Well done Brett, to everyone that's gotten in to date be it 2c or 29c.

Apart from having 3 plus years cash on hand, apart from having 6 genuine quality projects all firing, apart from gun management & low SOI.

I ask myself, how is a company like PTX with a market cap sub $200m attracting the board members it has? How are they attracting the 'Special Advisory Board' which is completely unpaid? How are they convincing the Peter MacCallum to dedicate 4 full-time clinicians to PTX portfolio? How are they getting Epworth & Professor Miles Prince to lead PTX-100 independently?

It's the equivalent of 6 Michelin star chefs walking into your family restaurant asking what smells so good on the stove?

Professor Phil Darcy- Head of Peter MacCallum CAR-T research, Professor Miles Prince- Head of Hematology at Epworth & world renowned, Professor Allen Ebens- Pioneer in CAR-T & prolific contributer to the science who took Juno to great heights, Professor Donald O'Rourke- World leading neurosurgeon at Penn University which is the birth place of CAR-T!

This company is sitting on some pretty bloody amazing bio tech & data already to date...How it's not already $500m-$1b escapes me? The IP is drawing these world leaders to us, they don't have time to sleep but they are jumping at PTX?

We are all seeing IMU race from $200m to almost $3b market cap...Well done to everyone across the pond.

I genuinely believe PTX is the next cab off the rank & I fully expect the company will breach $1b over the next 12-18 months as some pretty serious data starts to roll in and OmniCar hits arms for first time...In the mean time I expect another significant re-rate is imminent.

Expand

It's the equivalent of 6 Michelin star chefs walking into your family restaurant asking what smells so good on the stove?
Hahaha love the analogy.

PTX Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held
15 Upvote

1 Great analysis

Reply

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 4 more messages in this thread...

First 17 Last

Add PTX (ASX) to my watchlist

(20min delay)
Last 3.9¢		Change 0.000(0.00%)		Mkt cap ! $31.40M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.8¢	$16.31K	421.6K

Buyers (Bids)

No.	Vol.	Price($)
1	47849	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	73928	2

View Market Depth

No.	Vol.	Price($)
1	47849	0.039
5	707297	0.038
8	387500	0.037
5	708916	0.036
3	253590	0.035

Price($)	Vol.	No.
0.040	73928	2
0.041	200000	2
0.042	499154	4
0.043	449950	2
0.045	217151	3

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PTX (ASX) Chart

breakout, page-17

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before it can buy Namoi Cotton

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

breakout, page-17

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before it can buy Namoi Cotton

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News